Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 21492528)

Published in Euro Surveill on April 07, 2011

Authors

C A Ison1, J Hussey, K N Sankar, J Evans, S Alexander

Author Affiliations

1: Sexually Transmitted Bacteria Reference Laboratory, Health Protection Agency, London, United Kingdom. catherine.ison@hpa.org.uk

Articles citing this

High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother (2011) 3.00

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol (2012) 2.98

Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev (2014) 2.45

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Clin Infect Dis (2014) 1.87

In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob Agents Chemother (2012) 1.37

High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea. Antimicrob Agents Chemother (2014) 1.29

Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis (2015) 1.27

Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. J Clin Microbiol (2014) 1.19

Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother (2013) 1.11

Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins. BMC Infect Dis (2014) 1.05

Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother (2012) 1.01

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis (2013) 0.98

In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea? Antimicrob Agents Chemother (2012) 0.98

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011. BMC Infect Dis (2013) 0.95

Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis (2014) 0.92

Quantitative proteomics of the Neisseria gonorrhoeae cell envelope and membrane vesicles for the discovery of potential therapeutic targets. Mol Cell Proteomics (2014) 0.90

Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012. BMC Infect Dis (2014) 0.90

Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect Dis (2014) 0.89

Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway. Antimicrob Agents Chemother (2012) 0.89

Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012. BMC Infect Dis (2013) 0.87

Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol (2016) 0.87

The use of cephalosporins for gonorrhea: an update on the rising problem of resistance. Expert Opin Pharmacother (2012) 0.86

Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance. BMC Infect Dis (2015) 0.85

Enhancing the antibiotic antibacterial effect by sub lethal tellurite concentrations: tellurite and cefotaxime act synergistically in Escherichia coli. PLoS One (2012) 0.84

Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013. Antimicrob Agents Chemother (2014) 0.84

Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections. Indian J Sex Transm Dis (2015) 0.83

Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins. Eur J Clin Microbiol Infect Dis (2016) 0.83

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone. BMC Infect Dis (2014) 0.82

Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance. Sex Transm Infect (2011) 0.82

Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines. Eur J Clin Microbiol Infect Dis (2011) 0.79

The prevalence and epidemiology of plasmid-mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates in Guangzhou, China, 2002-2012. BMC Infect Dis (2015) 0.78

Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA. BMC Infect Dis (2013) 0.77

Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis. PLoS One (2014) 0.77

The Neisseria gonorrhoeae Obg protein is an essential ribosome-associated GTPase and a potential drug target. BMC Microbiol (2015) 0.77

Control of Neisseria gonorrhoeae in the era of evolving antimicrobial resistance. Infect Dis Clin North Am (2013) 0.76

Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial. Trials (2016) 0.75

Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). Antimicrob Agents Chemother (2015) 0.75

Gonorrhea: Treatment update for an increasingly resistant organism. Can Pharm J (Ott) (2015) 0.75

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015. Euro Surveill (2017) 0.75

Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines. PLoS Med (2017) 0.75

Peptide inhibitors targeting the Neisseria gonorrhoeae pivotal anaerobic respiration factor AniA. Antimicrob Agents Chemother (2017) 0.75

Prevention of Ophthalmia Neonatorum Caused by Neisseria gonorrhoeae Using a Fatty Acid-Based Formulation. MBio (2017) 0.75

Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013. Emerg Infect Dis (2017) 0.75

Articles by these authors

Rates and implications of caesarean sections in Latin America: ecological study. BMJ (1999) 9.86

Immunogenic structure of the influenza virus hemagglutinin. Cell (1982) 8.93

Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med (2001) 6.67

endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. Proc Natl Acad Sci U S A (1982) 6.64

Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol (1993) 6.47

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28

U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92

Toward a molecular genetic analysis of spermatogenesis in Drosophila melanogaster: characterization of male-sterile mutants generated by single P element mutagenesis. Genetics (1993) 3.75

Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet (1993) 3.72

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med (1998) 3.62

UK guidelines for the management of cutaneous melanoma. Br J Plast Surg (2002) 3.51

Demonstration of peptide:N-glycosidase F activity in endo-beta-N-acetylglucosaminidase F preparations. J Biol Chem (1984) 3.26

Audit of gonorrhoea test of cure at the genitourinary medicine department in Newcastle upon Tyne, UK. Int J STD AIDS (2003) 3.21

Randomised controlled trial of routine cervical examinations in pregnancy. European Community Collaborative Study Group on Prenatal Screening. Lancet (1994) 2.74

The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med (1998) 2.73

Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50

Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47

Outcome of pregnancy in a woman with an increased body mass index. BJOG (2005) 2.38

Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J Exp Med (1997) 2.38

Energy expended playing Xbox Kinect™ and Wii™ games: a preliminary study comparing single and multiplayer modes. Physiotherapy (2012) 2.34

Views of junior doctors about their work: survey of qualifiers of 1993 and 1996 from United Kingdom medical schools. Med Educ (2000) 2.29

Clinical predictors of admission in infants with acute bronchiolitis. Arch Dis Child (2011) 2.18

Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg (2005) 2.16

The ecological validity of tests of executive function. J Int Neuropsychol Soc (1998) 2.12

Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. (Official report from the International Society for Peritoneal Dialysis) Perit Dial Int (1998) 2.06

Early and late complications after pancreatic necrosectomy. Surgery (2005) 2.03

Screening for alcohol use disorders in a genitourinary medicine setting. Int J STD AIDS (2011) 2.02

The impact of maternal depression in pregnancy on early child development. BJOG (2008) 2.02

Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int (2001) 1.99

BD8 certification of visually impaired people. Br J Ophthalmol (1998) 1.96

The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem (1983) 1.94

Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) (1985) 1.93

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology (1996) 1.92

Retirement intentions of doctors who qualified in the United Kingdom in 1974: postal questionnaire survey. J Public Health Med (2001) 1.92

Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res (2001) 1.90

Beta-lactamase of R factors. J Bacteriol (1968) 1.89

Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics (2001) 1.78

Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet (1989) 1.78

Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology (2003) 1.78

Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science (1984) 1.77

Patients' choices and perceptions after an invitation to participate in treatment decisions. Soc Sci Med (1992) 1.72

CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol (1998) 1.72

A real-time quadriplex PCR assay for the diagnosis of rectal lymphogranuloma venereum and non-lymphogranuloma venereum Chlamydia trachomatis infections. Sex Transm Infect (2008) 1.70

Text entry on handheld computers by older users. Ergonomics (2000) 1.69

Principles for the management of penetrating cardiac wounds. Ann Surg (1979) 1.69

An examination of verbal working memory capacity in children with specific language impairment. J Speech Lang Hear Res (1999) 1.69

Vitamin D deficiency in pregnant women from a non-European ethnic minority population--an interventional study. BJOG (2002) 1.64

Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63

Genetic and molecular characterization of tube, a Drosophila gene maternally required for embryonic dorsoventral polarity. Proc Natl Acad Sci U S A (1991) 1.63

Ultrastructural studies of early morphogenesis and cytodifferentiation in the embryonic mammalian pancreas. Dev Biol (1968) 1.62

Antenatal domestic violence, maternal mental health and subsequent child behaviour: a cohort study. BJOG (2011) 1.60

Rectal chlamydia--a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect (2009) 1.59

Vancomycin for staphylococcal shunt site infections in patients on regular haemodialysis. Br Med J (1970) 1.59

Chronic neurodegenerative disease associated with HTLV-II infection. Lancet (1992) 1.58

Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ (2003) 1.56

Monoparesis. Complication of constant positive airways pressure. Arch Dis Child (1975) 1.54

Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. Tumori (1998) 1.54

Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London. Sex Transm Infect (2007) 1.53

Does glutamine contribute to immunosuppression after major burns? Lancet (1990) 1.53

Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int (2001) 1.52

Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol (1993) 1.51

Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG (2007) 1.51

Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (2000) 1.50

Physiological variation in circulating B cell:T cell ratio in man. Nature (1974) 1.50

Networking a need: a cost-effective approach to statewide health information delivery. Proc Annu Symp Comput Appl Med Care (1995) 1.49

The sheep-cell rosette: test on human peripheral blood lymyphocytes: an analysis of some analysis of some variable factors in the technique. Br J Haematol (1974) 1.49

The pros and cons of implementing PACS and speech recognition systems. J Digit Imaging (2001) 1.48

Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol (1998) 1.44

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol (1997) 1.44

Preoperative MRI sphincter morphology and anal manometry: can they be markers of functional outcome following anterior resection for rectal cancer? Colorectal Dis (2012) 1.44

Outcome of pregnancies associated with raised serum and normal amniotic fluid alpha fetoprotein concentrations. Br Med J (Clin Res Ed) (1984) 1.42

Population studies on Gilbert's syndrome. J Med Genet (1975) 1.42

Fractures of the Hip: Immediate versus Delayed Treatment. Can Med Assoc J (1960) 1.41

Treating oral candidiasis: potentially fatal. Br Dent J (1997) 1.41

General practitioners' prescribing data for multiple sclerosis patients indicates a link with asthma. Br J Gen Pract (2000) 1.41

Maternal mortality in developed countries: not just a concern of the past. Obstet Gynecol (1995) 1.41

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol (1995) 1.41

Experimental evacuation of the bladder by means of implanted electrodes. Br J Surg (1965) 1.40

Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology (2003) 1.40

'A mastectomy for something that wasn't even truly invasive cancer'. Women's understandings of having a mastectomy for screen-detected DCIS: a qualitative study. J Med Screen (2011) 1.40

Marathon of eponyms: 26 Zinsser-Engman-Cole syndrome (Dyskeratosis congenita). Oral Dis (2012) 1.40

Phantom breast pain. Plast Reconstr Surg (1998) 1.40

Distribution of Escherichia coli O157 in bovine fecal pats and its impact on estimates of the prevalence of fecal shedding. Appl Environ Microbiol (2004) 1.39

Receptor for motilin identified in the human gastrointestinal system. Science (1999) 1.39

Does bacterial vaginosis alter the sensitivity of screening tests for Chlamydia trachomatis? An analysis of patient characteristics. Int J STD AIDS (2003) 1.39

Closure of the urinary sphincter mechanism in anaesthetized dogs by means of electrical stimulation of the perineal muscles. Br J Surg (1966) 1.39

Gonorrhoea presenting with painful spontaneous erections. Int J STD AIDS (2002) 1.39

Prospective study of the SI-40NB foldable silicone intraocular lens. J Cataract Refract Surg (1996) 1.39

Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: the Framingham Study. Am Heart J (1998) 1.39

Exotic pets. Vet Rec (2000) 1.39

Neisseria gonorrhoeae in Newcastle upon Tyne 1995-1997: increase in ciprofloxacin resistance. Int J STD AIDS (1999) 1.39

Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells (2005) 1.38

The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study. Sex Transm Infect (2009) 1.37

Brain events related to normal and moderately scrambled faces. Brain Res Cogn Brain Res (1996) 1.36

The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology (2010) 1.36

A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest (1990) 1.35

Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol (2001) 1.35

CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet (2006) 1.35

Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol (2008) 1.34